Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the severity modifier on recent NICE recommendations on blood cancer treatments.

Since the introduction of the severity modifier, the National Institute for Health and Care Excellence has approved 27 out of 28 blood cancer medicines it evaluated, reflecting an approval rate of 96%. Of these topics, a severity weighting was applied in nine topics.